Figure 1From: Cellular tools for biosimilar mAb analysisAnalysis of accuracy and linearity of the Infliximab ADCC assay. Data shown are sample dose response curves (left) determined by 4PL analysis and mean rel. potency +/- SD (dot, n = 3) compared to the standard (right).Back to article page